Author:
Abern Michael R.,Tsivian Matvey,Moul Judd W.
Publisher
Springer Berlin Heidelberg
Reference21 articles.
1. Haas GP, Delongchamps N, Brawley OW, Wang CY, de la Roza G. The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Can J Urol. 2008;15(1):3866–71.
2. SEER cancer statistics review, 1975–2010.
http://seer.cancer.gov/csr/1975_2010/
.
3. Scosyrev E, Wu G, Mohile S, Messing EM. Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation: analysis of trends over time. Cancer. 2012;118(23):5768–76.
4. Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol. 1974;111(1):58–64.
5. D’Amico A, Whittington R, Malkowicz SB, et al. BIochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280(11):969–74.